Figure 1. The C-Mill and the 7 C-Gait walking-adaptability tasks.

Slides:

Advertisements

Similar presentations

Figure 1 Overall design of Query Health

Advertisements

Fig. 1. Significant clusters in the amygdala and dlPFC, four-way interaction effect (group by valence by temperature by time), small volume corrected.

From: Dynamic De/Centralization in Canada, 1867–2010

Figure 2. Chronic kidney disease risk tool application.

From: THE FALLACIES OF PATENT-HOLDUP THEORY

Fig. 1. Trial structure for the experimental task.

Fig. 1 Nodes in a conceptual knowledge graph

From: Nutrition and brain development in early life

From: Epidemiology of Inappropriate Empiric Antibiotic Therapy for Bacteremia Based on Discordant In vitro Susceptibilities: Risk factors and Taxon-level.

From: Detection of Bacteriuria by Canine Olfaction

Figure 1. Study population diagram

Figure 2 Mean pain intensity and pain relief over 12 hours of treatment (ITT population). *Difference from baseline (P

Figure 3. Scatterplot of hue and colour saturation (chroma) for the five Aphelocoma unicolor subspecies. From: Cloudy with a chance of speciation: integrative.

Figure 1: Necrobiosis lipoidica: Yellow-brown skin lesions with indurated borders located on both lower legs. Figure 1: Necrobiosis lipoidica: Yellow-brown.

ADAb: anti-drug antibody.

FIGURE 1 Kidney biopsies of Patients 1 and 2

Figure 1 Schematic representation of the extreme SVD design in the 3C-Dijon study. Unless provided in the caption above, the following copyright applies.

Figure 1: Axial T2 W images of penis showed a well-defined septated area of 2 cm in the posterior aspect of ... Figure 1: Axial T2 W images.

FIGURE 1 Histological diagnoses divided into 8-year time frames (n = 1208). Unless provided in the caption above, the following copyright applies to the.

FIGURE 1 The effect of daprodustat on hemoglobin (Hgb) levels

FIGURE 2 Responses to the question: regarding vasoactive drugs, does your centre use the following frequently, rarely ... FIGURE 2 Responses to the question:

FIGURE 1 Maternal (A) urinary aldosterone; (B) plasma active renin; (C) urinary AGT concentrations; and (D) plasma AGT ... FIGURE 1 Maternal (A) urinary.

FIGURE 1 Flow chart of patient enrollment and exclusion

Figure 1. Comparison of weighted estimates of diarrhoea prevalence in children under five by country between PMA Figure 1. Comparison of weighted.

Fig. 1 Kaplan-Meier plot of cumulative incidence of cancer onset following dermatomyositis diagnosis stratified ... Anti-TIF1-Ab: anti-transcriptional.

Figure 1 Flortaucipir PET MUBADA/PERSI SUVr at baseline, 9 and 18 months for individual subjects. Each subject is ... Figure 1 Flortaucipir PET MUBADA/PERSI.

Fig. 1 Mean change from baseline in ANC ± s. e

Point estimates with ... Point estimates with 95% CI. HR: hip replacement; KR: knee replacement. Unless provided in the caption above, the following copyright.

Figure 1. (A) Ab+ patients showed significantly more often a cognitive impairment compared with ab− patients [57.1% ... Figure 1. (A) Ab+ patients showed.

FIGURE 1 Participant flow diagram. Exercise Counseling Clinic (ECC).

Graph 1. The number of homicide cases per year discussing neuro-evidence. Unless provided in the caption above, the following copyright applies to the.

Figure 1. Analysis of human TRIM5α protein with Blast-Search and PhyML+SMS ‘One click’ workflow. (A) NGPhylogeny.fr ... Figure 1. Analysis of human TRIM5α.

Figure 2. Natural history of chlamydia transmission, with arrows showing the transitions between health states. Figure 2. Natural history of chlamydia.

Figure 1 Nelson-Aalen estimates of the cumulative incidence rates for patients on versus off IST. ON = optic neuritis; ... Figure 1 Nelson-Aalen estimates.

FIGURE 1 Malta: a plate-style food guide

FIGURE 1 Study consort diagram

Fig. 2 Case 2. Levels of serum creatinine and anti-GBM antibodies before and during treatment with cyclophosphamide, ... Fig. 2 Case 2. Levels of serum.

Figure 1. Illustration of DGR systems and their prediction using myDGR

Figure 1. The pipeline of Aggrescan3D 2.0 server.

FIGURE 1 Food groups consumed (mean, g/d) among US infants and young children by age group and tertile of mean ... FIGURE 1 Food groups consumed (mean,

Figure 1 Study flowchart and patient flow

Figure 1. Results of search based on the PRISMA statement.14

Figure 1. Prediction result for birch pollen allergen Bet v 1 (PDB: 1bv1), as obtained by comparison to the cherry ... Figure 1. Prediction result for.

Figure 4. Levels of cerebrospinal fluid (CSF) immune and inflammatory markers in participants grouped by CSF human ... Figure 4. Levels of cerebrospinal.

Figure 1. PaintOmics 3 workflow diagram

Figure 1. Schematic diagram of solar energy and coal-fired power generation system. Unless provided in the caption above, the following copyright applies.

Figure 1. Uncertainty reduction, value creation, and appropriation in two case studies. Unless provided in the caption above, the following copyright applies.

Figure 1 Ratio of the geometric mean concentration of hsTnT (A) and sST2 (B) at baseline (BL) and each subsequent ... Figure 1 Ratio of the geometric mean.

Figure 1. Time to clinical stability (a) and time to defervescence (b) in patients with pneumococcal pneumonia. ... Figure 1. Time to clinical stability.

Figure 1. MERMAID web server interface (Start page, Parameter page): MERMAID provides two ways to submit a protein ... Figure 1. MERMAID web server interface.

Figure 1. Yvis platform overview

Figure 1. The framework of NetGO with seven steps

Figure 1. Workflow of the HawkDock server that is divided into three major steps: (i) input of unbound or bound protein ... Figure 1. Workflow of the HawkDock.

Figure 1 Patient disposition

Figure 1 Diagram of patient and procedural follow-up for Cohorts A, B, and C. Cohort A: 6-month OCT and 12-month OCT, ... Figure 1 Diagram of patient and.

Figure 2. Result page of a Primer3Plus Cloning run showing the left and right primers in blue and yellow. The included ... Figure 2. Result page of a Primer3Plus.

Figure 1 BM community in the normozoospermic and iNOA human testis parenchyma. Quantification of the 16 S copies/ng in ... Figure 1 BM community in the.

Fig. 1. —Synteny analysis of melon chromosome 1 (brown) and cucumber chromosome 7 (green) based on melon-cucumber ... Fig. 1. —Synteny analysis of melon.

Figure 1. Trial profile. (A) Part A and (B) part B

Figure 1 Design of trials included in individual patient data meta-analysis. Unless provided in the caption above, the following copyright applies to the.

Figure 1. Scheme of a phosphorothioated-terminal hairpin formation and self-priming extension (PS-THSP) for selection ... Figure 1. Scheme of a phosphorothioated-terminal.

Figure 1. Excess cost of methicillin-resistant Staphylococcus aureus (MRSA) compared with methicillin-susceptible S. ... Figure 1. Excess cost of methicillin-resistant.

Figure 1. The proportion of CSBM responders over the 2-week treatment period (A), the proportion of SBM responders by ... Figure 1. The proportion of CSBM.

Figure 1 Genetic results. No case had more than one diagnostic result

Figure 1. (A) Baseline contrast-enhanced CT scan of melanoma patient presenting with metastases in the liver and lymph ... Figure 1. (A) Baseline contrast-enhanced.

Figure 1. Prevalence of parasitic infection and anemia among the children. Unless provided in the caption above, the following copyright applies to the.

Source:Zimnisky (2014). Source:Zimnisky (2014).

Figure 1 Mechanisms of mitral regurgitation.

Figure 3. Multiply-budding yeast-like cells of Blastomyces helicus in calcofluor white stain of bronchoalveolar fluid ... Figure 3. Multiply-budding yeast-like.

Figure 1. Hepatitis C screening and diagnostic algorithm at the MSF clinic, Karachi, Pakistan, March 2016–September ... Figure 1. Hepatitis C screening.

Presentation transcript:

Figure 1. The C-Mill and the 7 C-Gait walking-adaptability tasks. Unless provided in the caption above, the following copyright applies to the content of this slide: © 2019 American Physical Therapy Association.This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com Physical Therapy, Volume 99, Issue 7, 14 May 2019, Pages 882–892, https://doi.org/10.1093/ptj/pzz013 The content of this slide may be subject to copyright: please see the slide notes for details.

Figure 3. Acceptability results: patients’ experience (n = 26) after C-Gait training assessed with a custom-made ... Figure 3. Acceptability results: patients’ experience (n = 26) after C-Gait training assessed with a custom-made questionnaire, presented as the number of patients (n) per score for 7 items. Unless provided in the caption above, the following copyright applies to the content of this slide: © 2019 American Physical Therapy Association.This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com Physical Therapy, Volume 99, Issue 7, 14 May 2019, Pages 882–892, https://doi.org/10.1093/ptj/pzz013 The content of this slide may be subject to copyright: please see the slide notes for details.

Figure 2. Feasibility results: progress and between-patient variation in training content and execution parameters, ... Figure 2. Feasibility results: progress and between-patient variation in training content and execution parameters, performance, and perceived challenge over the 10 training sessions for the gait and/or balance deficits (GD) group (top 4 panels) and 2 representative cases (Participant A and Participant B) highlighted (lower 4 panels). Unless provided in the caption above, the following copyright applies to the content of this slide: © 2019 American Physical Therapy Association.This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com Physical Therapy, Volume 99, Issue 7, 14 May 2019, Pages 882–892, https://doi.org/10.1093/ptj/pzz013 The content of this slide may be subject to copyright: please see the slide notes for details.

Figure 4. Clinical potential: effect of C-Gait training on C-Gait baseline assessment scores (belt speed and composite ... Figure 4. Clinical potential: effect of C-Gait training on C-Gait baseline assessment scores (belt speed and composite score) and walking-related clinical measures—10-Meter Walking Test (10MWT), Timed “Up & Go” Test (TUG), Activities-specific Balance Confidence Scale (ABC), and Short Physical Performance Battery (SPPB). Error bars represent the standard error, and asterisks represent significant differences (P < .05) compared with the pretraining tests. Unless provided in the caption above, the following copyright applies to the content of this slide: © 2019 American Physical Therapy Association.This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com Physical Therapy, Volume 99, Issue 7, 14 May 2019, Pages 882–892, https://doi.org/10.1093/ptj/pzz013 The content of this slide may be subject to copyright: please see the slide notes for details.